Loading…

DiabetOmics has opened its first manufacturing facility in Hyderabad, India, to commercialize non-invasive diabetes tests. The plant, on a three-acre plot in Muppireddipally, will employ 100-120 people and produce 8-10 million test strips and 10,000-15,000 assembled readers annually.
“We are pleased to bring these innovative diagnostic tests to the market beginning later part of this year which will be a huge paradigm shift for the patients around the world particularly for emerging countries like India.”expresshealthcare.in
Summarized from public sources; check the original articles before acting on it.